Results 251 to 260 of about 284,364 (303)
Some of the next articles are maybe not open access.
Combined‐modality therapy for gastric cancer
Seminars in Surgical Oncology, 2003AbstractGastric cancer has a poor prognosis. It is often diagnosed at an advanced stage, and potentially curative treatments often can not be exercised. Even when a curative surgical resection is possible, only a minority of patients survive beyond 5 years, and locoregional failures are frequent among patients undergoing curative resections.
James C, Yao +6 more
openaire +2 more sources
Combined Modality Therapy for Rectal Cancer
The Cancer Journal, 2016The primary therapy for any potentially curative rectal cancer is surgery. For locally advanced tumors (i.e., T3-4 and/or node positive), the very high rate of local and distant recurrences has necessitated a standard adjuvant regimen of preoperative chemoradiation and postoperative chemotherapy.
Sagar A, Patel +2 more
openaire +2 more sources
Combined modality therapy of malignant melanoma
World Journal of Surgery, 1979AbstractThe major modalities of therapy, namely, surgery, radiotherapy, chemotherapy, and immunotherapy, are each of value in selected cases of malignant melanoma. However, because none of these therapies, alone, is capable of curing or controlling some subgroups of melanoma patients, combined modality therapy needs to be used more extensively. Surgery
E M, Hersh, J U, Gutterman, C M, McBride
openaire +2 more sources
Combined Modality Therapy of Esophageal Cancer
Journal of the National Comprehensive Cancer Network, 2008Esophageal cancer is a deadly disease. Only one third of patients with localized disease experience long-term survival. Over the past 20 years, investigators have evaluated neoadjuvant strategies to improve the outcomes of surgical management. Chemotherapy and radiation have been evaluated individually and in combination for preoperative management of ...
Rosalyn A, Juergens, Arlene, Forastiere
openaire +2 more sources
Combined Modality Therapy for Rectal Cancer
The Cancer Journal, 2010The standard adjuvant treatment for cT3 and/or N+ rectal cancer is preoperative chemoradiation. However, there are many controversies regarding this approach. These include the role of short course radiation, whether postoperative adjuvant chemotherapy necessary for all patients and whether the type of surgery after chemoradiation should be based on ...
Minsky, Bd +2 more
openaire +3 more sources
Combined modality therapy for intracranial tumors
Cancer, 1975Three types of tumor (supratentorial astrocytoma, medulloblastoma, and craniopharyngioma), each requiring a fundamentally different therapeutic approach, will be used to illustrate the principles and practice of combined treatment in this field. The role of radiotherapy and ways of enhancing the effect of irradiation will be considered.
openaire +2 more sources
Preoperative combined modality therapy for pancreatic cancer
World Journal of Surgery, 1995AbstractCombined modality therapy can be administered prior to surgical resection for patients with operable pancreatic cancer. One important criteria used to select patients for this treatment sequence is the absence of arterial vascular encasement by tumor on thin‐section CT scanning; the absence of peritoneal seeding on surgical staging or ...
T A, Rich, D B, Evans
openaire +2 more sources
Combined modality therapy for esophageal cancer
Seminars in Oncology, 2003Treatment approaches for esophageal cancer include primary treatment (surgical or nonsurgical) or adjuvant treatment (preoperative or postoperative). Primary treatments include surgery alone, radiation therapy alone, and radiation therapy plus chemotherapy (combined modality therapy).
openaire +2 more sources
Combined Modality Therapy in the Elderly Population
Current Treatment Options in Oncology, 2009The incidence of cancer among older patients continues to rise. The use of combined modality therapy has improved survival in a variety of malignancies, including rectal, head and neck, and lung cancer; however, the addition of chemotherapy increases substantially the toxicities of treatment.
Lilie L, Lin, Stephen M, Hahn
openaire +2 more sources
Combined modality therapy of acute lymphocytic leukemia
Cancer, 1975The progressive improvement in the prognosis of acute lymphocytic leukemia has been a result of two major developments: 1) the more efficient use of chemotherapeutic agents, particularly the use of combinations of agents and the discovery that agents effective at one stage of disease may be inappropriate at another stage, and 2) the prevention with ...
J V, Simone +4 more
openaire +2 more sources